Benzoylaconitine Alleviates Progression of Psoriasis via Suppressing STAT3 Phosphorylation in Keratinocytes
Molecules · 31.05.2023 · 28 (11) · 4473
DOI: 10.3390/molecules28114473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 31.05.2023. Verfasst von Yuanbo Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical College, Henan University of Chinese Medicine, Zhengzhou 450046, China. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Psoriasis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan University of Chinese Medicine, Henan Provincial Department of Science and Technology, Zhongjing Core Scholar’s Research Initial Fund of Henan University of Chinese Medicine.
Abstract (Originalsprache)
Psoriasis is a chronic and multifactorial skin disease which is caused by inflammatory infiltrates, keratinocyte hyperproliferation, and accumulation of immune cells. As part of the Aconitum species, Benzoylaconitine (BAC) shows potential antiviral, anti-tumor, and anti-inflammatory effects. In this study, we investigated the effects and mechanisms of BAC on tumor necrosis factor-alpha (TNF-α)/LPS-induced HaCaT keratinocytes in a imiquimod(IMQ)-induced mice model. The results showed that BAC could relieve the symptoms of psoriasis by inhibiting cell proliferation, the release of inflammatory factors, and the accumulation of Th17 cells, while no obvious effect on cell viability and safety was observed both in vitro and in vivo. Additionally, BAC can markedly inhibit the protein and mRNA levels of inflammatory cytokines in TNF-α/LPS-induced HaCaT keratinocytes by inhibiting the phosphorylation of STAT3. In brief, our data indicated that BAC could alleviate the progression of psoriasis and may be a potential therapeutic agent for treating psoriasis in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical College, Henan University of Chinese Medicine, Zhengzhou 450046, China.
- Key Laboratory of Human Functional Genomics of Jiangsu Province, Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing 211166, China.
- Department of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
ORCID-Profile: Shuxuan Li, Tao Guo, Shuying Feng
Förderung
- Henan University of Chinese Medicine
- Henan Provincial Department of Science and Technology
- Zhongjing Core Scholar’s Research Initial Fund of Henan University of Chinese Medicine
- Science and Technology Project of Henan Province
- Key scientific research Project of the University of Henan Province
Zitieren
APA
Li, Y., Guo, D., Wang, Q., Li, A., Yin, S., Li, S., Li, Y., Wang, B., Guo, T., & Feng, S. (2023). Benzoylaconitine Alleviates Progression of Psoriasis via Suppressing STAT3 Phosphorylation in Keratinocytes. Molecules, 28(11), 4473. https://doi.org/10.3390/molecules28114473
Vancouver
Li Y, Guo D, Wang Q, Li A, Yin S, Li S, et al. Benzoylaconitine Alleviates Progression of Psoriasis via Suppressing STAT3 Phosphorylation in Keratinocytes. Molecules. 2023;28(11):4473. doi:10.3390/molecules28114473
BibTeX
@article{Li2023,
author = {Li, Yuanbo and Guo, Dandan and Wang, Qianqian and Li, Aifang and Yin, Sugai and Li, Shuxuan and Li, Yalan and Wang, Baiyan and Guo, Tao and Feng, Shuying},
title = {Benzoylaconitine Alleviates Progression of Psoriasis via Suppressing STAT3 Phosphorylation in Keratinocytes},
journal = {Molecules},
year = {2023},
volume = {28},
number = {11},
pages = {4473},
doi = {10.3390/molecules28114473}
}
EUVIMED